Literature DB >> 17697962

T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

William Vernau1, Brian J Hartnett, Douglas R Kennedy, Peter F Moore, Paula S Henthorn, Kenneth I Weinberg, Peter J Felsburg.   

Abstract

Dogs with X-linked severe combined immunodeficiency (XSCID) can be successfully treated by bone marrow transplants (BMT) resulting in full immunologic reconstitution and engraftment of both donor B and T cells without the need for pretransplant conditioning. In this study, we evaluated the T cell diversity in XSCID dogs 4 months to 10.5 years following BMT. At 4 months posttransplantation, when the number of CD45RA+ (naïve) T cells had peaked and plateaued, the T cells in the transplanted dogs showed the same complex, diverse repertoire as those of normal young adult dogs. A decline in T cell diversity became evident approximately 3.5 years posttransplant, but the proportion of Vbeta families showing a polyclonal Gaussian spectratype still predominated up to 7.5 years posttransplant. In 2 dogs evaluated at 7.5 and 10.5 years posttransplant, >75% of the Vbeta families consisted of a skewed or oligoclonal spectratype that was associated with a CD4/CD8 ratio of <0.5. The decline in the complexity of T cell diversity in the transplanted XSCID dogs is similar to that reported for XSCID patients following BMT. However, in contrast to transplanted XSCID boys who show a significant decline in their T cell diversity by 10 to 12 years following BMT, transplanted XSCID dogs maintain a polyclonal, diverse T cell repertoire through midlife.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697962      PMCID: PMC2034291          DOI: 10.1016/j.bbmt.2007.05.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  61 in total

1.  The influence of age on T cell generation and TCR diversity.

Authors:  Keith Naylor; Guangjin Li; Abbe N Vallejo; Won-Woo Lee; Kerstin Koetz; Ewa Bryl; Jacek Witkowski; James Fulbright; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

2.  Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects.

Authors:  R Hingorani; I H Choi; P Akolkar; B Gulwani-Akolkar; R Pergolizzi; J Silver; P K Gregersen
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

3.  Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements.

Authors:  F Hulstaert; I Hannet; V Deneys; V Munhyeshuli; T Reichert; M De Bruyere; K Strauss
Journal:  Clin Immunol Immunopathol       Date:  1994-02

4.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

Authors:  C L Mackall; T A Fleisher; M R Brown; M P Andrich; C C Chen; I M Feuerstein; M E Horowitz; I T Magrath; A T Shad; S M Steinberg
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

5.  Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW).

Authors:  S Cobbold; S Metcalfe
Journal:  Tissue Antigens       Date:  1994-03

6.  T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency.

Authors:  R L Somberg; J P Robinson; P J Felsburg
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

Review 7.  Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

Authors:  J E van Leeuwen; M J van Tol; A M Joosten; P T Schellekens; R L van den Bergh; J L Waaijer; N J Oudeman-Gruber; C P van der Weijden-Ragas; M T Roos; E J Gerritsen
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

8.  IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease.

Authors:  P S Henthorn; R L Somberg; V M Fimiani; J M Puck; D F Patterson; P J Felsburg
Journal:  Genomics       Date:  1994-09-01       Impact factor: 5.736

9.  Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34.

Authors:  D DiGiusto; S Chen; J Combs; S Webb; R Namikawa; A Tsukamoto; B P Chen; A H Galy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

Review 10.  Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.

Authors:  R H Buckley; S E Schiff; R I Schiff; J L Roberts; M L Markert; W Peters; L W Williams; F E Ward
Journal:  Semin Hematol       Date:  1993-10       Impact factor: 3.851

View more
  9 in total

1.  Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.

Authors:  Douglas R Kennedy; Brian J Hartnett; Jeffrey S Kennedy; William Vernau; Peter F Moore; Thomas O'Malley; Linda C Burkly; Paula S Henthorn; Peter J Felsburg
Journal:  Vet Immunol Immunopathol       Date:  2011-04-14       Impact factor: 2.046

Review 2.  Gene therapy studies in a canine model of X-linked severe combined immunodeficiency.

Authors:  Peter J Felsburg; Suk See De Ravin; Harry L Malech; Brian P Sorrentino; Christopher Burtner; Hans-Peter Kiem
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-24       Impact factor: 5.032

3.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08

4.  Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.

Authors:  Douglas R Kennedy; Kyle McLellan; Peter F Moore; Paula S Henthorn; Peter J Felsburg
Journal:  Biol Blood Marrow Transplant       Date:  2009-06       Impact factor: 5.742

5.  Intravenous injection of a foamy virus vector to correct canine SCID-X1.

Authors:  Christopher R Burtner; Brian C Beard; Douglas R Kennedy; Martin E Wohlfahrt; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Troy R Torgerson; David J Rawlings; Peter J Felsburg; Hans-Peter Kiem
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

Review 6.  Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Authors:  Brittney L Gurda; Allison M Bradbury; Charles H Vite
Journal:  Yale J Biol Med       Date:  2017-09-25

Review 7.  Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Med Sci       Date:  2021-08-14

8.  In Vivo Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral Vector.

Authors:  Yogendra S Rajawat; Olivier Humbert; Savannah M Cook; Stefan Radtke; Dnyanada Pande; Mark Enstrom; Martin E Wohlfahrt; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2020-09-23       Impact factor: 5.695

9.  Perturbation of the T cell receptor repertoire occurs with increasing age in dogs.

Authors:  Angela Holder; Samantha M Mirczuk; Robert C Fowkes; Donald B Palmer; Richard Aspinall; Brian Catchpole
Journal:  Dev Comp Immunol       Date:  2017-10-28       Impact factor: 3.636

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.